In Q2 2024, Elevance Health achieved a gross profit of $13.07 billion, translating to a gross profit margin of 29.95%, which is a remarkable improvement both year-over-year and quarter-over-quarter, indicating enhanced operational efficiency. The company’s operating income stood at $3.03 billion with an operating income ratio of 6.93%, showcasing solid control over operating expenditures. Key year-over-year metrics show that while revenue experienced a slight contraction of 0.06%, strong growth in profitability metrics, particularly in net income and EPS growth (up 26.54% year-over-year), display an upward trajectory in financial health. Total assets reached $112.99 billion, while total liabilities amounted to $70.69 billion, reflecting a debt-to-equity ratio of 0.58, providing insight into a conservative leverage strategy that fortifies the company's balance sheet.